克服生物制药给药方面的挑战：制剂与递送策略。
Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies.
作者信息
Mitragotri Samir, Burke Paul A, Langer Robert
机构信息
Department of Chemical Engineering, Center for Bioengineering, University of California, Santa Barbara, California 92106, USA.
Burke Bioventures LLC, 277 Broadway, Cambridge, Massachusetts 02139, USA.
出版信息
Nat Rev Drug Discov. 2014 Sep;13(9):655-72. doi: 10.1038/nrd4363. Epub 2014 Aug 8.
Abstract
The formulation and delivery of biopharmaceutical drugs, such as monoclonal antibodies and recombinant proteins, poses substantial challenges owing to their large size and susceptibility to degradation. In this Review we highlight recent advances in formulation and delivery strategies--such as the use of microsphere-based controlled-release technologies, protein modification methods that make use of polyethylene glycol and other polymers, and genetic manipulation of biopharmaceutical drugs--and discuss their advantages and limitations. We also highlight current and emerging delivery routes that provide an alternative to injection, including transdermal, oral and pulmonary delivery routes. In addition, the potential of targeted and intracellular protein delivery is discussed.
摘要
生物制药药物，如单克隆抗体和重组蛋白，由于其分子量大且易降解，在制剂和给药方面面临重大挑战。在本综述中，我们重点介绍了制剂和给药策略的最新进展，如基于微球的控释技术的应用、利用聚乙二醇和其他聚合物的蛋白质修饰方法以及生物制药药物的基因操作，并讨论了它们的优缺点。我们还重点介绍了当前和新兴的给药途径，这些途径可替代注射给药，包括透皮、口服和肺部给药途径。此外，还讨论了靶向和细胞内蛋白质递送的潜力。
相似文献
1
Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies.
Nat Rev Drug Discov. 2014 Sep;13(9):655-72. doi: 10.1038/nrd4363. Epub 2014 Aug 8.
2
Formulation strategies and particle engineering technologies for pulmonary delivery of biopharmaceuticals.
Curr Pharm Des. 2015;21(19):2599-610. doi: 10.2174/1381612821666150416100800.
3
Application of in vitro biopharmaceutical methods in development of immediate release oral dosage forms intended for paediatric patients.
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):833-42. doi: 10.1016/j.ejpb.2013.04.015. Epub 2013 May 9.
4
Cubosomes as targeted drug delivery systems - a biopharmaceutical approach.
Curr Drug Discov Technol. 2014;11(3):181-8. doi: 10.2174/1570163811666140505125923.
5
Ocular biopharmaceutics: impact of modeling and simulation on topical ophthalmic formulation development.
Drug Discov Today. 2019 Aug;24(8):1587-1597. doi: 10.1016/j.drudis.2019.04.002. Epub 2019 Apr 5.
6
An integrated early formulation strategy--from hit evaluation to preclinical candidate profiling.
Eur J Pharm Biopharm. 2007 Apr;66(1):1-10. doi: 10.1016/j.ejpb.2006.09.011. Epub 2006 Oct 6.
7
Cyclodextrin-based pharmaceutics: past, present and future.
Nat Rev Drug Discov. 2004 Dec;3(12):1023-35. doi: 10.1038/nrd1576.
8
Design of PLGA-based depot delivery systems for biopharmaceuticals prepared by spray drying.
Int J Pharm. 2016 Feb 10;498(1-2):82-95. doi: 10.1016/j.ijpharm.2015.12.025. Epub 2015 Dec 11.
9
Recent advances on self modified patch for (trans) dermal drug delivery.
Recent Pat Drug Deliv Formul. 2015;9(1):88-94. doi: 10.2174/187221130901150303113918.
10
Prospects of formulating proteins/peptides as aerosols for pulmonary drug delivery.
Int J Pharm. 2006 May 11;314(1):1-8. doi: 10.1016/j.ijpharm.2006.02.014. Epub 2006 Mar 24.
引用本文的文献
1
Encapsulation of Therapeutic, Low-Molecular-Weight Chemokines Using a Single Emulsion, Microfluidic, Continuous Manufacturing Process.
Pharmaceutics. 2025 Aug 14;17(8):1056. doi: 10.3390/pharmaceutics17081056.
2
Impact of Obesity on Immunity to the Influenza Virus: Gut Microbiota, Mechanisms, and Novel Therapeutic Strategies.
Diseases. 2025 Aug 19;13(8):267. doi: 10.3390/diseases13080267.
3
Biopharmaceutical analysis - current analytical challenges, limitations, and perspectives.
Anal Bioanal Chem. 2025 Aug 12. doi: 10.1007/s00216-025-06036-2.
4
The particle drifting effect in vivo: impact of dose and animal species.
Int J Pharm. 2025 Aug 7;683:126060. doi: 10.1016/j.ijpharm.2025.126060.
5
Spider venom peptides with unique fold selectively block Shaker-type potassium channels.
Cell Mol Life Sci. 2025 Aug 8;82(1):300. doi: 10.1007/s00018-025-05778-7.
6
Engineered acetylated inulin nanoparticles for enhanced oral insulin delivery: sustained release, structural stability, and efficacy.
RSC Adv. 2025 Jul 22;15(32):26216-26228. doi: 10.1039/d5ra03627e. eCollection 2025 Jul 21.
7
Self-Assembling Aromatic Peptide Amphiphile Fibers for Multivalent Display of Enzymatically Linked Antigenic Proteins.
ACS Appl Mater Interfaces. 2025 Aug 6;17(31):44240-44248. doi: 10.1021/acsami.5c10222. Epub 2025 Jul 23.
8
Breaking the cellular delivery bottleneck: recent developments in direct cytosolic delivery of biologics.
RSC Pharm. 2025 Jul 2. doi: 10.1039/d5pm00129c.
9
Competent expression of effective and long-acting human α-Gal A-Fc fusion protein in the milk of transgenic mice.
Transgenic Res. 2025 Jul 2;34(1):33. doi: 10.1007/s11248-025-00452-x.
10
Application of Biomimetic Cell Membrane-Coated Nanocarriers in Cardiovascular Diseases.
Int J Nanomedicine. 2025 Jun 26;20:8249-8289. doi: 10.2147/IJN.S531558. eCollection 2025.
本文引用的文献
1
RNAi therapies: drugging the undruggable.
Sci Transl Med. 2014 Jun 11;6(240):240ps7. doi: 10.1126/scitranslmed.3008362.
2
Investigating the impact of nanoparticle size on active and passive tumor targeting efficiency.
ACS Nano. 2014 Jun 24;8(6):5696-706. doi: 10.1021/nn500299p. Epub 2014 May 22.
3
Chemoimmunotherapy using pegylated liposomal Doxorubicin and interleukin-18 in recurrent ovarian cancer: a phase I dose-escalation study.
Cancer Immunol Res. 2013 Sep;1(3):168-78. doi: 10.1158/2326-6066.CIR-13-0098. Epub 2013 Jul 31.
4
Observation of small cluster formation in concentrated monoclonal antibody solutions and its implications to solution viscosity.
Biophys J. 2014 Apr 15;106(8):1763-70. doi: 10.1016/j.bpj.2014.02.036.
5
Controlling microencapsulation and release of micronized proteins using poly(ethylene glycol) and electrospraying.
Eur J Pharm Biopharm. 2014 Jul;87(2):366-77. doi: 10.1016/j.ejpb.2014.03.008. Epub 2014 Mar 20.
6
Scaffold-mediated lentiviral transduction for functional tissue engineering of cartilage.
Proc Natl Acad Sci U S A. 2014 Mar 4;111(9):E798-806. doi: 10.1073/pnas.1321744111. Epub 2014 Feb 18.
7
Antiamyloid therapy for Alzheimer's disease--are we on the right road?
N Engl J Med. 2014 Jan 23;370(4):377-8. doi: 10.1056/NEJMe1313943.
8
Increased brain penetration and potency of a therapeutic antibody using a monovalent molecular shuttle.
Neuron. 2014 Jan 8;81(1):49-60. doi: 10.1016/j.neuron.2013.10.061.
9
The role of citric acid in oral peptide and protein formulations: relationship between calcium chelation and proteolysis inhibition.
Eur J Pharm Biopharm. 2014 Apr;86(3):544-51. doi: 10.1016/j.ejpb.2013.12.017. Epub 2013 Dec 31.
10
An observational 7-year study of continuous subcutaneous insulin infusion for the treatment of type 1 diabetes mellitus.
Endocrinol Nutr. 2014 Mar;61(3):141-6. doi: 10.1016/j.endonu.2013.09.003. Epub 2013 Dec 17.
Zotero 插件